Journey Net Income from 2010 to 2026
| DERM Stock | USD 8.36 0.09 1.07% |
Net Loss | First Reported 2014-12-31 | Previous Quarter -3.8 M | Current Value -2.3 M | Quarterly Volatility 34 M |
Check Journey Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Journey Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.2 M, Interest Expense of 4 M or Selling General Administrative of 52.9 M, as well as many indicators such as Price To Sales Ratio of 1.55, Dividend Yield of 0.0 or PTB Ratio of 3.81. Journey financial statements analysis is a perfect complement when working with Journey Medical Valuation or Volatility modules.
Journey | Net Income | Build AI portfolio with Journey Stock |
Evaluating Journey Medical's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Journey Medical Corp's fundamental strength.
Latest Journey Medical's Net Income Growth Pattern
Below is the plot of the Net Income of Journey Medical Corp over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Journey Medical Corp financial statement analysis. It represents the amount of money remaining after all of Journey Medical Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Journey Medical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Journey Medical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (14.67 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Journey Net Income Regression Statistics
| Arithmetic Mean | (57,028,661) | |
| Coefficient Of Variation | (144.47) | |
| Mean Deviation | 54,608,159 | |
| Median | (31,875,000) | |
| Standard Deviation | 82,387,842 | |
| Sample Variance | 6787.8T | |
| Range | 308.5M | |
| R-Value | 0.16 | |
| Mean Square Error | 7053.4T | |
| R-Squared | 0.03 | |
| Significance | 0.54 | |
| Slope | 2,621,164 | |
| Total Sum of Squares | 108604.1T |
Journey Net Income History
Other Fundumenentals of Journey Medical Corp
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Journey Medical Net Income component correlations
About Journey Medical Financial Statements
Journey Medical investors utilize fundamental indicators, such as Net Income, to predict how Journey Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Loss | -16.9 M | -17.7 M | |
| Net Loss | -13.2 M | -13.9 M | |
| Net Loss | -26.7 M | -25.3 M | |
| Net Loss | (0.65) | (0.68) | |
| Net Income Per E B T | 0.90 | 0.76 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Journey Medical Correlation against competitors. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Will Biotechnology sector continue expanding? Could Journey diversify its offerings? Factors like these will boost the valuation of Journey Medical. Projected growth potential of Journey fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Journey Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.35) | Revenue Per Share | Quarterly Revenue Growth 0.205 | Return On Assets | Return On Equity |
Understanding Journey Medical Corp requires distinguishing between market price and book value, where the latter reflects Journey's accounting equity. The concept of intrinsic value—what Journey Medical's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Journey Medical's price substantially above or below its fundamental value.
It's important to distinguish between Journey Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Journey Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Journey Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.